Institution statistics

CELGENE MANAGEMENT SARL - CH 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 8.728.185 0 1
2020 0 6.715.625 0 1
2019 0 8.713.395 0 1
2018 0 14.105.750 0 1
2017 0 23.749.833 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV4
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE4
NOVARTIS PHARMA4
BAYER3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPEAN HEMATOLOGY ASSOCIATION3
OSPEDALE PEDIATRICO BAMBINO GESU3
PFIZER LIMITED3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
UNIVERSIDAD DE NAVARRA3
ABBVIE INC2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
AMGEN2
BAYER AKTIENGESELLSCHAFT2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
ELI LILLY AND COMPANY LIMITED2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GENOME RESEARCH2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
LEUKANET EV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MASARYKOVA UNIVERZITA2
MEDISAPIENS OY2
MEDIZINISCHE UNIVERSITAET WIEN2
MENARINI RICERCHE2
MLL MUNCHNER LEUKAMIELABOR2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
STICHTING VUMC2
STIFTUNG ELN FOUNDATION2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE LYMPHOMA STUDY ASSOCIATION2
UCB BIOPHARMA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET ULM2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
VIB VZW2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA AB1
BARTS AND THE LONDON NHS TRUST1
BAYER PHARMA1
BIOSCI CONSULTING BVBA1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DRUGS FOR NEGLECTED DISEASES INITIATIVE FONDATION DNDI1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN PATIENTS' FORUM1
F HOFFMANNLA ROCHE1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FOLKEHELSEINSTITUTTET1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
HEALTH IQ LIMITED1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
IFAKARA HEALTH INSTITUTE TRUST1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DU CANCER GIP1
INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT1
INTERSYSTEMS1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MILTENYI BIOTEC BV & CO KG1
MUSEUM NATIONAL D'HISTOIRE NATURELLE1
NOVO NORDISK1
ODYSSEUS DATA SERVICES SRO1
SEMMELWEIS EGYETEM1
STATENS LEGEMIDDELVERK1
STIFTELSEN WHO COLLABORATING CENTRE FOR INTERNATIONAL DRUG MONITORING1
SWISS TROPICAL INSTITUTE1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TANDVARDSOCH LAKEMEDELSFORMANSVERKET1
TARTU ULIKOOL1
TCURX1
Constancy:

Total number of partners:179

Partner loyalty:
Frequent Partner: (> 2 projects): 33
Rare Partner: 146

Frequent / Rare Partner Ratio: 0.23

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62539
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum